
About Guerir Pharmaceuticals Private Limited
Data last updated:
Guerir Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52399DL2016PTC308768. Its GSTIN is 07AAGCG6071J1ZE (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Avinash Singh and Amit Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 246 Office No 301 – 302 3rd Floor Balaji Chambe Gali No – 10 Vikas Marg Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.48 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹7.26 Lakh (net margin 2.9%) and EBITDA of ₹17.75 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
The company is associated with 1 brand: Guerir Pharmaceuticals. As per MCA filings, the company has open charges of ₹30 Lakh and satisfied charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website guerir.in.
Company details
Contact details
Guerir Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is guerir.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 246 Office No 301 – 302 3rd Floor Balaji Chambe Gali No – 10 Vikas Marg Laxmi Nagar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Guerir Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Guerir Pharmaceuticals operates one associated brand: Guerir Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and healthcare solutions are provided by Guerir Pharma, focusing on antibiotics, supplements, and therapeutic innovations. | guerirpharma.com |
Business activity
The main business activity of Guerir Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Guerir Pharmaceuticals Private Limited, buy the company report.
Financials of Guerir Pharmaceuticals Private Limited
FY 2025 filings availableGuerir Pharmaceuticals Private Limited reported revenue of ₹2.48 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 9% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Guerir Pharmaceuticals Private Limited, buy the company report.
Board of directors of Guerir Pharmaceuticals Private Limited
Guerir Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avinash Singh Also directs: Rama Hotels and Resorts Private Limited | Director | 01 Dec 2016 | 9 Years 11 Months | Current |
| Amit Singh | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Guerir Pharmaceuticals Private Limited is audited by M A S A R & CO. for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M A S A R & CO. | FY 2020 | 033829N |
Shareholding
The shareholding of Guerir Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Guerir Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2017 | 100123981 | Others | ₹30 Lakh | Open | |
| 07 Feb 2017 | 100082845 | Indian Overseas Bank | ₹15 Lakh | Satisfied |
To see the full charge records of Guerir Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Guerir Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Guerir Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Guerir Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCG6071J1ZE | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Guerir Pharmaceuticals Private Limited, buy the company report.
Recent activity
Guerir Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Amit Singh was appointed as Director on 29 Sep 2018.
Frequently asked questions
Guerir Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 2016 (10+ years old) and is registered under CIN U52399DL2016PTC308768.
Guerir Pharmaceuticals has 2 current directors:
- Avinash Singh - Director
- Amit Singh - Director
The latest financial statements of Guerir Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Guerir Pharmaceuticals is 07AAGCG6071J1ZE, registered in Delhi.
The CIN (Corporate Identification Number) of Guerir Pharmaceuticals is U52399DL2016PTC308768. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Guerir Pharmaceuticals was incorporated on 01 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Singh was appointed as Director on 29 Sep 2018. Nagendra Singh ceased to be Director on 29 Sep 2018. Avinash Singh was appointed as Director on 01 Dec 2016.
Guerir Pharmaceuticals can be reached through the website guerir.in. Its registered office is in Delhi, India.
The registered office of Guerir Pharmaceuticals is at D – 246 Office No 301 – 302 3rd Floor Balaji Chambe Gali No – 10 Vikas Marg Laxmi Nagar, Delhi, India – 110092.
Guerir Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

